These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29662402)

  • 21. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients.
    Smitz J; Andersen AN; Devroey P; Arce JC;
    Hum Reprod; 2007 Mar; 22(3):676-87. PubMed ID: 17110397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follicular fluid hormone concentrations after ovarian stimulation using gonadotropin preparations with different FSH/LH ratios. I. Comparison of an FSH-dominant and a purified FSH preparation.
    Duijkers IJ; Willemsen WN; Hollanders HM; Hamilton CJ; Thomas CM; Vemer HM
    Int J Fertil Womens Med; 1997; 42(5):306-10. PubMed ID: 9406836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oocyte maturation inhibitor activity in human follicular fluid: quantitative determination in unstimulated and clomiphene citrate- and human menopausal gonadotropin-stimulated ovarian cycles.
    Winer-Sorgen S; Brown J; Ono T; Gale JA; Campeau JD; Marrs RP; Dizerega GS
    J In Vitro Fert Embryo Transf; 1986 Aug; 3(4):218-23. PubMed ID: 3093614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon).
    de Jong D; Macklon NS; Eijkemans MJ; Mannaerts BM; Coelingh Bennink HJ; Fauser BC;
    Fertil Steril; 2001 Apr; 75(4):688-93. PubMed ID: 11287020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlations between steroids concentration in follicular fluid, pronuclear morphology and embryo qualities in
    Hasegawa J; Iwasaki S; Yanaihara A; Negishi M; Tahara R; Okai T
    Reprod Med Biol; 2003 Dec; 2(4):171-176. PubMed ID: 29699180
    [No Abstract]   [Full Text] [Related]  

  • 28. IVF characteristics and the molecular luteal features of random start IVF cycles are not different from conventional cycles in cancer patients.
    Esmaeilian Y; Hela F; Bildik G; Akin N; İltumur E; Yusufoglu S; Yildiz CS; Keles İ; Vatansever D; Taskiran C; Yakin K; Oktem O
    Hum Reprod; 2023 Jan; 38(1):113-124. PubMed ID: 36367834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandin F2 alpha, progesterone and estradiol concentrations in human follicular fluid and their relation to success of in vitro fertilization.
    Suchanek E; Simunic V; Macas E; Kopjar B; Grizelj V
    Eur J Obstet Gynecol Reprod Biol; 1988 Aug; 28(4):331-9. PubMed ID: 3139478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone.
    Balasch J; Miró F; Burzaco I; Casamitjana R; Civico S; Ballescá JL; Puerto B; Vanrell JA
    Hum Reprod; 1995 Jul; 10(7):1678-83. PubMed ID: 8582960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of luteinizing hormone pulses in cattle influences duration of persistence of dominant ovarian follicles, follicular fluid concentrations of steroids, and activity of insulin-like growth factor binding proteins.
    Kojima FN; Bergfeld EG; Wehrman ME; Cupp AS; Fike KE; Mariscal-Aguayo DV; Sanchez-Torres T; Garcia-Winder M; Clopton DT; Roberts AJ; Kinder JE
    Anim Reprod Sci; 2003 Jul; 77(3-4):187-211. PubMed ID: 12695054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Steroid and protein hormone concentrations in serum and follicular fluid after stimulation for in vitro fertilization].
    Zech H; Weiss P; Fritzsche H; Zech J; Daxenbichler G
    Geburtshilfe Frauenheilkd; 1992 Aug; 52(8):483-6. PubMed ID: 1397945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
    Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
    Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovulation induction with human menopausal gonadotropin compared to human urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa-luteal cell function.
    Polan ML; Daniele A; Russell JB; DeCherney AH
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1284-91. PubMed ID: 3097055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gonadotrophin stimulation in IVF alters the immune cell profile in follicular fluid and the cytokine concentrations in follicular fluid and serum.
    Kollmann Z; Schneider S; Fux M; Bersinger NA; von Wolff M
    Hum Reprod; 2017 Apr; 32(4):820-831. PubMed ID: 28201504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clomiphene-HMG ovarian stimulation in human in vitro fertilization and embryo transfer].
    Oda T; Yoshimura S; Sumi Y; Shiina M; Yahagi M; Matsumoto C; Ohno T; Hara S; Nakamura Y; Iizuka R
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2059-66. PubMed ID: 3935741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follicular fluid hormone concentrations during controlled ovarian hyperstimulation using gonadotropin preparations with different FSH/LH ratios. I. Comparison of an FSH-dominant and a purified FSH preparation.
    Duijkers IJ; Willemsen WN; Hollanders HM; Hamilton CJ; Thomas CM; Vemer HM
    Int J Fertil Womens Med; 1997; 42(6):426-30. PubMed ID: 9459088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of letrozole co-treatment during ovarian stimulation with gonadotrophins for IVF: a multicentre, randomized, double-blinded placebo-controlled trial.
    Bülow NS; Skouby SO; Warzecha AK; Udengaard H; Andersen CY; Holt MD; Grøndahl ML; Nyboe Andersen A; Sopa N; Mikkelsen ALE; Pinborg A; Macklon NS
    Hum Reprod; 2022 Jan; 37(2):309-321. PubMed ID: 34792133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follicular fluid hormonal profile and cumulus cell gene expression in controlled ovarian hyperstimulation with recombinant FSH: effects of recombinant LH administration.
    Barberi M; Ermini B; Morelli MB; Ermini M; Cecconi S; Canipari R
    J Assist Reprod Genet; 2012 Dec; 29(12):1381-91. PubMed ID: 23188412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.